ホーム › 肝臓がん（肝細胞がん） › マサチューセッツ州 › Boston
Boston、MAにおける肝臓がん（肝細胞がん）の臨床試験
Bostonとその周辺地域（約30マイル以内）の拠点で、肝臓がん（肝細胞がん）に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #7, Boston
National Liver Cancer Screening Trial
被験者募集中第4相
- Massachusetts General Hospital, Boston
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
被験者募集中第1相
- Mass General Cancer Center, Boston
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
被験者募集中第2相
- Massachusetts General Hospital, Boston
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
被験者募集中観察研究
- Mass General Brigham, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
被験者募集中第1/2相
- Dana-Farber Cancer Institute, Boston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
被験者募集中第3相
- Massachusetts General Hospital Cancer Center, Boston
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
被験者募集中第1/2相
- Research Site, Boston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
被験者募集中第2相
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
被験者募集中第1/2相
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
被験者募集中
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
被験者募集中第1相
- Mass General Brigham Cancer Institute, Boston
- Dana Farber Cancer Institute, Boston
Computer Guided Microwave Liver Ablation
被験者募集中
- Massachusetts General Hospital, Boston
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
被験者募集中第2相
- Children's Hospital Boston, Boston
- Dana Farber Cancer Institute, Boston
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
被験者募集中第4相
- Massachussets General Hospital, Boston
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
被験者募集中観察研究
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown · 1マイル先
Psychoeducational Intervention for Patients With Hepatocellular Carcinoma
被験者募集中
- Massachusetts General Hospital, Boston
他の都市における肝臓がん（肝細胞がん）の試験
- Houston, TX31件の研究
- New York City, NY24件の研究
- Dallas, TX19件の研究
- Los Angeles, CA19件の研究
- Cleveland, OH18件の研究
- Chicago, IL16件の研究
- Philadelphia, PA16件の研究
- Pittsburgh, PA15件の研究
- San Francisco, CA14件の研究
- Orange, CA14件の研究
- Jacksonville, FL14件の研究
- San Antonio, TX13件の研究
Bostonにおける他の研究
- 乳がん112件の研究
- 非小細胞肺癌90件の研究
- がん（全種類）85件の研究
- 転移性癌63件の研究
- 大腸癌63件の研究
- 肺がん62件の研究
- 卵巣がん61件の研究
- 前立腺がん59件の研究
- うつ病52件の研究
- 子宮内膜がん50件の研究
- 心不全44件の研究
- 急性骨髄性白血病44件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。